NO870946L - FremgangsmŸte og preparat for vekstŸkning av parenkymvev i melkekjertler. - Google Patents

FremgangsmŸte og preparat for vekstŸkning av parenkymvev i melkekjertler.

Info

Publication number
NO870946L
NO870946L NO870946A NO870946A NO870946L NO 870946 L NO870946 L NO 870946L NO 870946 A NO870946 A NO 870946A NO 870946 A NO870946 A NO 870946A NO 870946 L NO870946 L NO 870946L
Authority
NO
Norway
Prior art keywords
parencym
growing
tissue
procedure
preparation
Prior art date
Application number
NO870946A
Other languages
English (en)
Norwegian (no)
Other versions
NO870946D0 (no
Inventor
Robert Joseph Collier
Michael Francis Mcgrath
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of NO870946D0 publication Critical patent/NO870946D0/no
Publication of NO870946L publication Critical patent/NO870946L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Dairy Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Prostheses (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Liquid Deposition Of Substances Of Which Semiconductor Devices Are Composed (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Seasonings (AREA)
  • Mushroom Cultivation (AREA)
NO870946A 1986-03-07 1987-03-06 FremgangsmŸte og preparat for vekstŸkning av parenkymvev i melkekjertler. NO870946L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83747786A 1986-03-07 1986-03-07

Publications (2)

Publication Number Publication Date
NO870946D0 NO870946D0 (no) 1987-03-06
NO870946L true NO870946L (no) 1987-09-08

Family

ID=25274560

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870946A NO870946L (no) 1986-03-07 1987-03-06 FremgangsmŸte og preparat for vekstŸkning av parenkymvev i melkekjertler.

Country Status (22)

Country Link
US (1) US5059586A (fr)
EP (1) EP0237514B1 (fr)
JP (1) JPS62221635A (fr)
KR (1) KR900000545B1 (fr)
CN (1) CN87102601A (fr)
AT (1) ATE93730T1 (fr)
AU (1) AU595295B2 (fr)
BG (1) BG50926A3 (fr)
CA (1) CA1299103C (fr)
CS (1) CS272772B2 (fr)
DD (1) DD258943A5 (fr)
DE (1) DE3787185T2 (fr)
DK (1) DK116287A (fr)
ES (1) ES2000437T3 (fr)
HU (1) HU205007B (fr)
IL (1) IL81809A (fr)
MX (1) MX170911B (fr)
NO (1) NO870946L (fr)
NZ (1) NZ219530A (fr)
PL (1) PL154182B1 (fr)
RU (1) RU2033178C1 (fr)
ZA (1) ZA871654B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182302A (en) * 1986-03-07 1993-01-26 Monsanto Company Method for enhancing growth of mammary parenchyma using a prostaglandin
US5130300A (en) * 1986-03-07 1992-07-14 Monsanto Company Method for enhancing growth of mammary parenchyma
US5130299A (en) * 1986-03-07 1992-07-14 Monsanto Company Method for enhancing growth of mammary parenchyma
IE912345A1 (en) * 1990-08-03 1992-02-12 Pharmacia Ab Treatment of human lactation failure
US5336488A (en) * 1991-08-07 1994-08-09 American Cyanamid Company Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines
US6828111B2 (en) 2000-01-13 2004-12-07 Wayne State University Three-dimensional in vitro model of human preneoplastic breast disease
RU2185198C2 (ru) * 2000-05-15 2002-07-20 Российский Университет Дружбы Народов Способ лечения кисты молочной железы
JP2004536589A (ja) * 2001-05-18 2004-12-09 カナダ国 ウシ上皮成長因子の核酸及びタンパク質配列
JP2017046688A (ja) * 2015-08-31 2017-03-09 株式会社みやぎヘルスイノベーション 体重増加抑制用飲料組成物
CN105194642B (zh) * 2015-10-09 2018-04-17 深圳市容大生物技术有限公司 一种疏通乳房微循环养护自体腺胞的组合物及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011312A (en) * 1975-06-25 1977-03-08 American Home Products Corporation Prolonged release drug form for the treatment of bovine mastitis
EP0085036A1 (fr) * 1982-01-18 1983-08-03 Monsanto Company Méthode pour une production améliorée de lait de bovins
US4521409A (en) * 1983-10-03 1985-06-04 Cornell Research Foundation, Inc. Use of growth hormone to enhance ruminant mammary development

Also Published As

Publication number Publication date
EP0237514A1 (fr) 1987-09-16
ZA871654B (en) 1987-08-28
ES2000437T3 (es) 1994-01-16
CS151887A2 (en) 1990-06-13
BG50926A3 (bg) 1992-12-15
AU595295B2 (en) 1990-03-29
NZ219530A (en) 1992-12-23
MX170911B (es) 1993-09-22
NO870946D0 (no) 1987-03-06
HU205007B (en) 1992-03-30
HUT47031A (en) 1989-01-30
PL154182B1 (en) 1991-07-31
CN87102601A (zh) 1987-12-16
AU6978887A (en) 1987-09-10
ATE93730T1 (de) 1993-09-15
CS272772B2 (en) 1991-02-12
IL81809A (en) 1993-01-31
KR900000545B1 (ko) 1990-01-31
EP0237514B1 (fr) 1993-09-01
IL81809A0 (en) 1987-10-20
CA1299103C (fr) 1992-04-21
DK116287D0 (da) 1987-03-06
DD258943A5 (de) 1988-08-10
PL264490A1 (en) 1988-02-18
KR880010773A (ko) 1988-10-24
ES2000437A4 (es) 1988-03-01
JPS62221635A (ja) 1987-09-29
DE3787185D1 (de) 1993-10-07
DK116287A (da) 1987-09-08
DE3787185T2 (de) 1994-02-03
US5059586A (en) 1991-10-22
RU2033178C1 (ru) 1995-04-20

Similar Documents

Publication Publication Date Title
SE8104661L (sv) Stabil mikrokristallin form av cisplatin, forfarande for framstellning derav samt stabil, steril torrblandningsberedning derav
FI875533L (fi) Insulinpreparat foer non-parenteral dosering.
DK336986D0 (da) Fremgangsmaade til fremstilling af toerre biologisk aktive rekombinante vaeksthormoner
CA2010321A1 (fr) Proteine de surface de cellules associees aux lymphocytes
NO870946D0 (no) Fremgangsmaate og preparat for vekstoekning av parenkymvev i melkekjertler.
NO940180L (no) Anvendelse av IGF-I
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
IT1275556B (it) Procedimento ed impianto per la disidratazione di foraggio, particolarmente per la disidratazione dell'erba medica
ES2038969T3 (es) Procedimiento para la renaturalizacion de proteinas.
SE8204874D0 (sv) Farmaceutiska preparat, innefattande humant insulin och humant proinsulin
ATE107168T1 (de) Verwendung von gepiron zur herstellung eines pharmazeutischen präparats zur behandlung atypischer depression.
ATE22655T1 (de) Infusionsloesungen zur herztherapie.
SE8400723L (sv) Farmaceutisk komposition
WO1989000166A3 (fr) Peptides relatifs a l'hormone de croissance
Hume et al. Anaemia of Felty's syndrome
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
DK447488D0 (da) Forbedringer vedroerende anvendelsen af epidermal vaekstfaktor
ATE40795T1 (de) Verwendung eines zerebral und peripher wirkenden antihypoxidotikums.
Millard et al. Effect of cysteamine on suckling-induced prolactin secretion in the rat
XIE et al. A Clinical Study of Tolbutamide to Improve Hypermetabolisnl in Burn Patients
Narayanan Evidence for endogenous protein inhibitor (s) of sarcoplasmic reticulum calcium pump in heart and slow skeletal muscle
IT8648752A0 (it) 3-(2-metil-butil)-8-n-propilxantina,ad attivita' antibroncospastica,suoi sali fisiologicamente accettabili,composizioni farmaceutiche e procedimento per la sua preparazione
IT1068920B (it) Procedimento per la preparazione di prodotti proteici,da utilizzarsi per l'alimentazione di animali in genere